Moody’s assigns Elevance notes Baa2

Moody's Investors Service said it assigned a Baa2 senior unsecured debt rating to Elevance Health, Inc.'s expected issuance of senior unsecured debt due in 2025, 2032 and 2052.

Elevance will use the proceeds for general corporate purposes, including, but not limited to, repayment of debt, share repurchase and acquisitions.

“This issuance will not have a material impact on Elevance's credit profile, as we expect the proceeds from the issuance to be used, in part, to refinance the $750 million of notes due in December 2022 and $1.0 billion of notes maturing in January 2023,” Moody’s said in a press release.

The outlook on Elevance is stable.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.